Pilar de la Huerta has been CFO of Biofrontera AG since September 2022. 

Mrs. de la Huerta has more than 20 years’ experience in the pharma and biotech industries and has held a number of CEO positions in private and public companies over that time. She also acted as a strategic consultant to several companies, such as Viamed Salud Group or Arquimea Group. Mrs. de la Huerta holds a Master’s Degree in Business and Administration by the Universidad Complutense de Madrid and has completed the IESE’s Advanced Management Program (AMP) and Program for Management Development (PMD) courses in  Navarra University.

Beside her Chief Financial Officer position at Biofrontera AG she is on the board of 4basebio Plc (holding the chair position of the RemCom),  board member of several other smaller Spanish healthcare R&D spin-offs companies, part time professor at Universidad Francisco de Vitoria, Spain, and permanent advisor of the Fundacion Botin (Banco de Santander) science program.